Neoadjuvant therapy in resectable and borderline pancreatic adenocarcinomas

被引：0
|
作者：
Perez Casanova, L. [1 ]
Serrano, T. [1 ]
Fabregat, J. [1 ]
Valls, C. [1 ]
Laquente, B. [1 ]
Condom, E. [1 ]
机构：
[1] Bellvitge Hosp, Dept Patol, Lhospitalet De Llobregat, Spain
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-19-048
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [42] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [43] Venous Thromboembolism Prophylaxis During Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer-Is it indicated?
    Krepline, Ashley N.
    Christians, Kathleen K.
    George, Ben
    Ritch, Paul S.
    Erickson, Beth A.
    Tolat, Parag
    Evans, Douglas B.
    Tsai, Susan
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (05) : 581 - 586
  • [44] Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
    Cloyd, Jordan M.
    Heh, Victor
    Pawlik, Timothy M.
    Ejaz, Aslam
    Dillhoff, Mary
    Tsung, Allan
    Williams, Terence
    Abushahin, Laith
    Bridges, John F. P.
    Santry, Heena
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [45] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [46] Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma
    Kang, J.
    Kim, K-P.
    Yoo, C.
    Lee, J-L.
    Ryoo, B-Y.
    Chang, H-M.
    Lee, S. S.
    Park, D. H.
    Song, T. J.
    Seo, D. W.
    Lee, S. K.
    Kim, M-H.
    Hwang, D. W.
    Song, K. B.
    Lee, J. H.
    Kim, S. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    di Sebastiano, Pierluigi
    Grottola, Tommaso
    di Mola, F. Francesco
    UPDATES IN SURGERY, 2016, 68 (03) : 235 - 239
  • [48] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [49] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [50] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
12345